Increased use of drug-eluting stents, ICDs nets higher costs for patients

May 20, 2010

Increased use of drug-eluting stents (DES) and implantable cardioverter-defibrillators (ICDs) between 2003 and 2006 netted significantly higher costs for coronary artery disease and chronic heart failure patients, researchers said.

The increased use of these technologies also partly explained the growth in healthcare costs during these years.

DES and ICDs are among the most common and costly interventional therapies used in patients with cardiovascular disease.

In the study, researchers looked at the fiscal impact of these devices by examining Medicare claims from 2003 to 2006 and separately identifying groups of patients between ages 66 and 85 in each year diagnosed with coronary artery disease and chronic . They calculated annual average cost of care, as well as the average use rate of DES for coronary artery disease and ICDs for chronic heart failure.

The researchers found:

  • The average inflation-adjusted costs for coronary artery disease patients increased from $12,160 in 2003 to $12,721 in 2006.
  • The average costs for chronic heart failure patients increased from $17,153 in 2003 to $18,371 in 2006.
  • The average cost increase for coronary artery disease patients treated with DES was $412, while the average cost increase for chronic heart failure patients with ICDs was $189.
As a result, between 2003 and 2006, the total cost increase attributable to DES in the Medicare population ages 66 to 85 was $3.32 billion (73 percent of total growth). The total cost increase in the Medicare chronic heart failure population attributable to ICDs was $774 million (15 percent of total growth).

Related Stories

Recommended for you

Novel therapies for multidrug-resistant bacteria

October 23, 2017
During this innovative study published in PLOS One, researchers found that novel classes of compounds, such as metal-complexes, can be used as alternatives to or to supplement traditional antibiotics, which have become ineffective ...

Key discoveries offer significant hope of reversing antibiotic resistance

October 23, 2017
Resistance to antibiotics is becoming increasingly prevalent and threatens to undermine healthcare systems across the globe. Antibiotics including penicillins, cephalosporins and carbapenems are known as β-lactams and are ...

Exploring how herpes simplex virus changes when passed between family members

October 22, 2017
A new study explores how herpes simplex virus might change when passed from one individual to another, information that may prove useful in future development of therapeutics and vaccines. This rare glimpse into a transmission ...

Pneumonia vaccine under development provides 'most comprehensive coverage' to date, alleviates antimicrobial concerns

October 20, 2017
In 2004, pneumonia killed more than 2 million children worldwide, according to the World Health Organization. By 2015, the number was less than 1 million.

Newly discovered viral marker could help predict flu severity in infected patients

October 20, 2017
Flu viruses contain defective genetic material that may activate the immune system in infected patients, and new research published in PLOS Pathogens suggests that lower levels of these molecules could increase flu severity.

Migraines may be the brain's way of dealing with oxidative stress

October 19, 2017
A new perspective article highlights a compelling theory about migraine attacks: that they are an integrated mechanism by which the brain protects and repairs itself. Recent insightful findings and potential ways to use them ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.